🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06884657
Recruiting Phase 4

Effect of Mannitol on Propofol Level

NCT06884657 · tracked via the Priya Life Science Turkey tracker
Phase
Phase 4
Started
2025-03-20
Last updated
2025-09-02

Condition(s) studied

Mannitol Adverse Reaction

Investigational drug(s) / intervention(s)

mannitol →Saline

mannitol: 2.5 mg/kg Mannitol will be given intravenously

Saline: 2.5 ml/kg saline will be given as plasebo

Study summary

Group 1 will include 20 patients aged 18 years and over, American Society of Anesthesiologist (ASA) II-III class, who will undergo supratentorial tumor surgery, and Group 2 will include 20 patients who will undergo pituitary surgery without mannitol. Total intravenous anesthesia (TIVA) will be adjusted to propofol 4 µg/dl and remifentanil 2-4 µg/dl with target-controlled infusion pumps. In the mannitol group, 2.5 ml/kg (0.5 g/kg) will be given to all patients 20 minutes after induction and the mannitol infusion will be adjusted to be 10 minutes.In Group 2, mannitol will not be used and 2.5 ml/kg isotonic will be administered in 10 minutes. Both blood and urine samples will take for measurement to propofol levels.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * American Society of Anesthesiologist (ASA) II participants * supratentorial tumor surgery * eligible for mannitol use * eligible for Total intravenous anesthesia (TIVA) Exclusion Criteria: * American Society of Anesthesiologist (ASA) III and upper * Chronic kidney failure * sepsis * multiorgan failure

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Çukurova University Çukurova Adana Recruiting

More Cukurova University trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06884657 on ClinicalTrials.gov ↗ ← All trials in Turkey